Back to search
FDAFDA · Food and drugs·Recall number D-0341-2026

Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15.

Published March 4, 2026 · Recall initiated: February 13, 2026

Summary

FDA records drug Class II recall D-0341-2026, published March 4, 2026 and initiated February 13, 2026. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: N/A; Lot: Lot # 49261, Exp: 04/30/27. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email if AMANTADINE HCL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMANTADINE HCL
Manufacturer
AvKARE
Distributor
Nationwide in the USA.
Lot
Lot # 49261, Exp: 04/30/27
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15. recalled?

Yes. FDA published recall D-0341-2026 on March 4, 2026. Reported hazard: Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMANTADINE HCL.